SBI Life Insuran

  • Market Cap: Large Cap
  • Industry: Insurance
  • ISIN: INE123W01016
  • NSEID: SBILIFE
  • BSEID: 540719
INR
2,055.00
16.2 (0.79%)
BSENSE

Jan 28

BSE+NSE Vol: 14.92 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: SBI Life Insuran will declare its result soon on 28 Jan 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

14.92 lacs (5.81%) Volume

Shareholding (Dec 2025)

FII

21.88%

Held by 863 FIIs

DII

2.44%

Held by 85 DIIs

Promoter

55.34%

What does SBI Life Insuran do?

06-Jun-2025

SBI Life Insurance Company Ltd, established in 2001 as a joint venture between the State Bank of India and BNP Paribas Cardif S.A., is a leading life insurance provider in India with a market cap of Rs 178,198 Cr and reported net sales of 23,861 Cr and net profit of 814 Cr for March 2025. Key metrics include a P/E ratio of 74.00 and a return on equity of 14.21%.

Overview:<BR>SBI Life Insurance Company Ltd is a leading life insurance provider in India, operating within the large-cap insurance industry.<BR><BR>History:<BR>Established in 2001, SBI Life Insurance is a joint venture between the State Bank of India and BNP Paribas Cardif S.A. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 23,861 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 814 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 178,198 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 74.00<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.15%<BR>- Debt-Equity: -0.11<BR>- Return on Equity: 14.21%<BR>- Price to Book: 10.46<BR><BR>Contact Details:<BR>Address: Natraj M V Road Andheri(East), Western Express Highway Juncti Mumbai Maharashtra : 400069<BR>Tel: 91-22-61910000<BR>Email: investor@sbilife.co.in/aniket.karan<BR>Website: http://www.sbilife.co.in

View full answer

Has SBI Life Insuran declared dividend?

06-Jun-2025

Yes, SBI Life Insurance has declared a 27% dividend, amounting to ₹2.7 per share, with an ex-date of March 7, 2025. The company has shown strong total returns across various periods, reflecting its robust financial health.

SBI Life Insurance Company Ltd has declared a 27% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 27%<BR>- Amount per share: 2.7<BR>- Ex-date: 07 Mar 25<BR><BR>Dividend Yield: 0.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 22.37%, the dividend return was 0.18%, leading to a total return of 22.55%.<BR><BR>Over the past year, the price return was 22.87%, the dividend return was 0.19%, resulting in a total return of 23.06%.<BR><BR>In the last 2 years, the price return was 44.93%, the dividend return was 0.42%, culminating in a total return of 45.35%.<BR><BR>For the 3-year period, the price return was 55.37%, the dividend return was 0.74%, which brought the total return to 56.11%.<BR><BR>In the 4-year span, the price return was 79.25%, the dividend return was 0.99%, leading to a total return of 80.24%.<BR><BR>Over the last 5 years, the price return was 122.45%, the dividend return was 1.52%, resulting in a total return of 123.97%.<BR><BR>Overall, SBI Life Insurance has declared a substantial dividend alongside strong total returns across various periods, indicating a positive performance for investors. The consistent growth in both price and dividend returns reflects the company's robust financial health.

View full answer

Is SBI Life Insuran overvalued or undervalued?

09-Jun-2025

As of April 28, 2025, SBI Life Insurance Co. Ltd. is considered undervalued with a valuation grade shift to very attractive, featuring a PE ratio of 74.03, an EV to EBIT of 131.31, and a year-to-date return of 28.59%, outperforming the Sensex's 5.58%.

As of 28 April 2025, the valuation grade for SBI Life Insurance Co. Ltd. has moved from very expensive to very attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 74.03, an EV to EBIT of 131.31, and a ROE of 14.21%. <BR><BR>In comparison to its peers, SBI Life's valuation metrics align closely with those of similar companies, such as HDFC Life Insurance, which has a PE ratio of approximately 70.00, and ICICI Prudential Life Insurance, with an EV to EBITDA of around 120.00. Notably, SBI Life has outperformed the Sensex with a year-to-date return of 28.59% compared to the Sensex's 5.58%, reinforcing its attractiveness as an investment opportunity.

View full answer

Who are the peers of the SBI Life Insuran?

16-Jul-2025

SBI Life Insurance's peers include HDFC Life, ICICI Lombard, ICICI Prudential Life, Max Financial, and others. It has an average growth rating and a 1-year return of 12.48%, lower than Max Financial's 50.88% but higher than New India Assurance's -35.73%.

Peers: The peers of SBI Life Insuran are Life Insurance, HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Go Digit General, New India Assura, Star Health Insu, and Niva Bupa Health.<BR><BR>Quality Snapshot: Excellent management risk is observed at ICICI Lombard and Go Digit General, while Average management risk is found at Life Insurance, SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, and Niva Bupa Health, and Below Average management risk is noted at New India Assura. Growth is rated as Excellent for Go Digit General and Niva Bupa Health, Good for HDFC Life Insur., Average for SBI Life Insuran, Life Insurance, General Insuranc, Max Financial, and Star Health Insu, and Below Average for ICICI Pru Life and New India Assura. All peers have an Excellent capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Max Financial at 50.88%, while the peer with the lowest is New India Assura at -35.73%. SBI Life Insuran's 1-year return is 12.48%, which is higher than New India Assura but lower than Max Financial. Additionally, General Insuranc, ICICI Pru Life, New India Assura, and Star Health Insu have negative six-month returns.

View full answer

Who are in the management team of SBI Life Insuran?

16-Jul-2025

As of March 2023, the management team of SBI Life Insurance includes Chairman Dinesh Kumar Khara, Managing Director & CEO Mahesh Kumar Sharma, and several independent non-executive directors: Deepak Amin, Narayan Seshadri, Shobinder Duggal, T M Bhasin, and Usha Sangwan.

As of March 2023, the management team of SBI Life Insurance includes the following members:<BR><BR>1. Dinesh Kumar Khara - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. Deepak Amin - Independent Non-Executive Director<BR>3. Narayan Seshadri - Independent Non-Executive Director<BR>4. Shobinder Duggal - Independent Non-Executive Director<BR>5. T M Bhasin - Independent Non-Executive Director<BR>6. Usha Sangwan - Independent Non-Executive Director<BR>7. Mahesh Kumar Sharma - Managing Director & CEO<BR><BR>This team comprises a mix of executive and independent directors, with Mahesh Kumar Sharma serving as the CEO.

View full answer

Who are the top shareholders of the SBI Life Insuran?

17-Jul-2025

The top shareholders of SBI Life Insurance are the State Bank of India with 55.38%, followed by foreign institutional investors at 21.88%, and mutual funds holding 15%. ICICI Prudential Mutual Fund is the largest public shareholder with 4.35%, while individual investors own 2.02%.

The top shareholders of SBI Life Insurance include the State Bank of India, which holds the largest stake at 55.38%. In addition, foreign institutional investors (FIIs) collectively own 21.88% of the shares, while mutual funds have a significant presence with 15.0% held across 42 schemes. The highest public shareholder is ICICI Prudential Mutual Fund, specifically the ICICI Prudential NI, which holds 4.35%. Individual investors account for 2.02% of the holdings.

View full answer

How big is SBI Life Insuran?

24-Jul-2025

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, with recent Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr. Shareholder's Funds are 14,908.56 Cr and Total Assets are valued at 3,98,298.81 Cr as of March 2024.

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 14,908.56 Cr and Total Assets valued at 3,98,298.81 Cr.

View full answer

How has been the historical performance of SBI Life Insuran?

24-Oct-2025

SBI Life Insurance has shown consistent growth, with net sales increasing from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, and profit after tax rising from 1,326.80 Cr to 2,413.30 Cr during the same period. Total liabilities and assets both reached 4,57,095.46 Cr in Mar'25, while cash flow from operating activities improved to 25,546.00 Cr.

Answer:<BR>The historical performance of SBI Life Insurance shows a consistent growth trajectory in net sales, with figures rising from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25. Other operating income fluctuated significantly, peaking at 51,400.69 Cr in Mar'24 before dropping to 32,828.59 Cr in Mar'25. Total operating income also saw a peak in Mar'24 at 1,31,987.79 Cr, followed by a decline to 1,16,888.42 Cr in Mar'25. The operating profit (PBDIT) has shown an upward trend, increasing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25. Profit after tax has similarly risen, reaching 2,413.30 Cr in Mar'25, up from 1,326.80 Cr in Mar'19. The earnings per share (EPS) grew from 13.27 in Mar'19 to 24.08 in Mar'25. On the balance sheet, total liabilities increased from 1,65,580.06 Cr in Mar'20 to 4,57,095.46 Cr in Mar'25, while total assets rose from 1,65,580.06 Cr to 4,57,095.46 Cr in the same period. Cash flow from operating activities also improved, reaching 25,546.00 Cr in Mar'25, although cash flow from investing activities remained negative.<BR><BR>Breakdown:<BR>SBI Life Insurance has demonstrated significant growth in net sales, which increased from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, indicating a strong upward trend. Other operating income varied, with a high of 51,400.69 Cr in Mar'24 before decreasing to 32,828.59 Cr in Mar'25. Total operating income peaked at 1,31,987.79 Cr in Mar'24 but fell to 1,16,888.42 Cr in Mar'25. Operating profit (PBDIT) has shown a positive trend, climbing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25, while profit after tax rose from 1,326.80 Cr to 2,413.30 Cr over the same period. The earnings per share (EPS) also increased significantly from 13.27 to 24.08. On the balance sheet, total liabilities and total assets both grew substantially, with total liabilities rising to 4,57,095.46 Cr and total assets matching this figure in Mar'25. Cash flow from operating activities improved to 25,546.00 Cr, despite ongoing negative cash flow from investing activities.

View full answer

Is SBI Life Insuran technically bullish or bearish?

28-Oct-2025

As of 27 October 2025, the trend is bullish with moderate strength, supported by positive daily moving averages and monthly Bollinger Bands, although caution is advised due to mildly bearish weekly indicators; the stock has outperformed the Sensex with a year-to-date return of 36.58%.

As of 27 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include the bullish signals from the daily moving averages and the monthly Bollinger Bands, alongside a bullish monthly MACD. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The stock has shown strong performance relative to the Sensex over various time frames, particularly with a year-to-date return of 36.58% compared to 8.50% for the index.

View full answer

When is the next results date for SBI Life Insurance Company Ltd?

21-Jan-2026

The next results date for SBI Life Insurance Company Ltd is January 28, 2026.

The next results date for SBI Life Insurance Company Ltd is scheduled for January 28, 2026.

View full answer

Why is SBI Life Insurance Company Ltd falling/rising?

28-Jan-2026

As of 27-Jan, SBI Life Insurance Company's stock price is rising to 2,038.80, reflecting a recovery after previous declines and strong annual performance with a 43.11% return. Increased investor participation and solid fundamentals further support its attractive valuation.

As of 27-Jan, SBI Life Insurance Company Ltd's stock price is rising, currently at 2,038.80, reflecting an increase of 35.15 (1.75%). This upward movement follows a trend reversal after two consecutive days of decline. Despite opening with a loss of 2.86%, the stock managed to reach an intraday high of Rs 2046.2, indicating a recovery during the trading session.<BR><BR>The stock's performance over the past year has been strong, with a return of 43.11%, significantly outperforming the Sensex, which only gained 8.61% in the same period. Additionally, the stock has shown impressive long-term growth, with a 63.05% increase over three years and a remarkable 131.22% rise over five years. <BR><BR>Investor participation has also increased, as evidenced by a delivery volume of 7.92 lacs on January 23, which is up by 22.46% compared to the five-day average. This suggests growing interest and confidence among investors. Furthermore, the company maintains a low debt-to-equity ratio and strong fundamental strengths, which contribute to its attractive valuation and market-beating performance. <BR><BR>Overall, the combination of a recent price recovery, strong historical performance, and rising investor participation are key factors contributing to the stock's current rise.

View full answer

Are SBI Life Insurance Company Ltd latest results good or bad?

28-Jan-2026

SBI Life Insurance Company's latest Q3 FY26 results show strong revenue growth with a net profit of ₹576.74 crore, up 21.82% year-on-year. However, slight declines in profit margins raise concerns about future profitability, suggesting a mixed outlook for investors.

SBI Life Insurance Company Ltd's latest results for Q3 FY26 present a mixed picture. On the positive side, the company reported a net profit of ₹576.74 crore, which reflects a 4.71% increase quarter-on-quarter and a significant 21.82% increase year-on-year. Additionally, net sales surged to ₹30,245 crore, marking a robust 21.72% growth from the previous quarter and also a 21.82% increase compared to the same quarter last year.<BR><BR>However, there are concerns regarding profitability margins. The profit after tax (PAT) margin decreased slightly to 1.91%, down from 1.99% in the previous quarter, indicating some pressure on profitability despite strong revenue growth. Similarly, the operating margin (excluding other income) also saw a small decline to 2.03%.<BR><BR>Overall, while the revenue growth is impressive and indicates strong market performance, the slight erosion in margins raises questions about the company's ability to maintain profitability in a competitive environment. Investors may view the results as good in terms of growth but should remain cautious about the margin pressures that could impact future performance.

View full answer

Should I buy, sell or hold SBI Life Insurance Company Ltd?

28-Jan-2026
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

With ROE of 13.4, it has a Very Attractive valuation with a 11.3 Price to Book Value

4

High Institutional Holdings at 40.6%

5

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Insurance

stock-summary
Market cap

INR 205,435 Cr (Large Cap)

stock-summary
P/E

84.00

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

0.13%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

13.41%

stock-summary
Price to Book

11.17

Revenue and Profits:
Net Sales:
30,245 Cr
(Quarterly Results - Dec 2025)
Net Profit:
577 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.13%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.17%
0%
6.17%
6 Months
11.29%
0%
11.29%
1 Year
44.8%
0.19%
44.99%
2 Years
48.83%
0.37%
49.2%
3 Years
64.35%
0.67%
65.02%
4 Years
70.37%
0.86%
71.23%
5 Years
135.6%
1.43%
137.03%

Latest dividend: 2.7 per share ex-dividend date: Mar-07-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

23-Jan-2026 | Source : BSE

Please find attached newspaper publication in relation to intimation to concerned shareholders about transfer of unclaimed dividend amount and shares to IEPF Authority.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

22-Jan-2026 | Source : BSE

The Company will be hosting an earnings conference call with analysts and investors at 16:00 (IST) on January 28 2026 to update the performance of the Company for the nine months ended December 31 2025. An audio recording and transcript of the earnings call will be hosted on the Companys website at www.sbilife.co.in

Board Meeting Intimation for Considering And Approving Audited Financial Results For The Quarter And Nine Months Ended December 31 2025.

20-Jan-2026 | Source : BSE

SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve audited financial results for the quarter and nine months ended December 31 2025.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

(28 Jan 2026)

stock-summary
DIVIDEND

SBI Life Insurance Company Ltd has declared 27% dividend, ex-date: 07 Mar 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.18%
EBIT Growth (5y)
-0.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
7.75
Tax Ratio
9.72%
Dividend Payout Ratio
11.21%
Pledged Shares
0
Institutional Holding
40.60%
ROCE (avg)
5.75%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
84
Industry P/E
22
Price to Book Value
11.26
EV to EBIT
154.04
EV to EBITDA
154.04
EV to Capital Employed
12.34
EV to Sales
1.96
PEG Ratio
6.80
Dividend Yield
0.13%
ROCE (Latest)
8.01%
ROE (Latest)
13.41%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 45 Schemes (15.01%)

FIIs

Held by 863 FIIs (21.88%)

Promoter with highest holding

State Bank Of India (55.34%)

Highest Public shareholder

Icici Prudential Mutual Fund Schemes (4.28%)

Individual Investors Holdings

2.01%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 21.82% vs 11.25% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 4.71% vs 71.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30,245.32",
          "val2": "24,827.54",
          "chgp": "21.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "615.27",
          "val2": "596.30",
          "chgp": "3.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "576.74",
          "val2": "550.82",
          "chgp": "4.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.03%",
          "val2": "2.40%",
          "chgp": "-0.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 18.82% vs 6.69% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 3.81% vs 37.80% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42,026.81",
          "val2": "35,371.58",
          "chgp": "18.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,179.46",
          "val2": "1,199.33",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1,088.96",
          "val2": "1,048.97",
          "chgp": "3.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.81%",
          "val2": "3.39%",
          "chgp": "-0.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 20.06% vs 8.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 4.12% vs 47.72% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72,272.13",
          "val2": "60,199.12",
          "chgp": "20.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,794.73",
          "val2": "1,795.63",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1,665.70",
          "val2": "1,599.79",
          "chgp": "4.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.66%",
          "val2": "1.91%",
          "chgp": "-0.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 4.31% vs 21.04% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 27.43% vs 10.07% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "84,059.83",
          "val2": "80,587.10",
          "chgp": "4.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,346.47",
          "val2": "400.11",
          "chgp": "236.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2,413.30",
          "val2": "1,893.78",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.60%",
          "val2": "0.50%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
30,245.32
24,827.54
21.82%
Operating Profit (PBDIT) excl Other Income
615.27
596.30
3.18%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
576.74
550.82
4.71%
Operating Profit Margin (Excl OI)
2.03%
2.40%
-0.37%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 21.82% vs 11.25% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 4.71% vs 71.20% in Dec 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
42,026.81
35,371.58
18.82%
Operating Profit (PBDIT) excl Other Income
1,179.46
1,199.33
-1.66%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1,088.96
1,048.97
3.81%
Operating Profit Margin (Excl OI)
2.81%
3.39%
-0.58%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 18.82% vs 6.69% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 3.81% vs 37.80% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
72,272.13
60,199.12
20.06%
Operating Profit (PBDIT) excl Other Income
1,794.73
1,795.63
-0.05%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1,665.70
1,599.79
4.12%
Operating Profit Margin (Excl OI)
1.66%
1.91%
-0.25%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 20.06% vs 8.52% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 4.12% vs 47.72% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
84,059.83
80,587.10
4.31%
Operating Profit (PBDIT) excl Other Income
1,346.47
400.11
236.52%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
2,413.30
1,893.78
27.43%
Operating Profit Margin (Excl OI)
1.60%
0.50%
1.10%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 4.31% vs 21.04% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 27.43% vs 10.07% in Mar 2024

stock-summaryCompany CV
About SBI Life Insurance Company Ltd stock-summary
stock-summary
SBI Life Insurance Company Ltd
Large Cap
Insurance
SBI Life Insurance Company Limited (SBI Life), established in 2001, is a Joint Venture between State Bank of India (SBI) and French Financial Institution, BNP Paribas Cardif S.A. and is one of the leading life Insurance companies in India. SBI has an unrivaled strength of over 40,000 branches across the country, making it the largest banking group in India. BNP Paribas Cardif S.A. is the life and property & casualty insurance arm of BNP Paribas, one of the strongest banks in the world.
Company Coordinates stock-summary
Company Details
Natraj M V Road Andheri(East), Western Express Highway Juncti Mumbai Maharashtra : 400069
stock-summary
Tel: 91-22-61910000
stock-summary
investor@sbilife.co.in/aniket.karan
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad